Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Kctd15 (potassium channel tetramerization domain containing 15) Rattus norvegicus
Analyze
Symbol: Kctd15
Name: potassium channel tetramerization domain containing 15
Description: Predicted to have identical protein binding activity. Predicted to be involved in protein homooligomerization. Orthologous to human KCTD15 (potassium channel tetramerization domain containing 15); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; bisphenol A; cisplatin.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: BTB/POZ domain-containing protein KCTD15; LOC499129; potassium channel tetramerisation domain containing 15; similar to potassium channel tetramerisation domain containing 15
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0190,506,697 - 90,522,217 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0191,645,833 - 91,661,530 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4187,117,385 - 87,130,690 (-)NCBIRGSC3.4rn4RGSC3.4
Celera181,623,383 - 81,636,586 (-)NCBICelera
Cytogenetic Map1q21NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated
RGD Disease Portals

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Kctd15
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1583737
Created: 2006-11-19
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.